Literature DB >> 8668378

Role of xanthine oxidase and its inhibitor in hypoxia: reoxygenation injury.

O D Saugstad1.   

Abstract

OBJECTIVE: This article reviews the biochemistry and function of xanthine dehydrogenase (XDH) and xanthine oxidase (XO) as well as their role in hypoxia-reoxygenation injury. Possible benefits of XO blockade are discussed.
METHODOLOGY: The available literature was reviewed.
RESULTS: It is evident that relatively high activities of XO are restricted to a few organs in man. Because positive effects of XO blockade with allopurinol have been reported even in organs containing relatively low activities of XO, two other possible favorable actions of allopurinol are mentioned. First it may act as an oxygen radical scavenger, and second, it may augment the adenine nucleotides and, hence, adenosine triphosphate concentration in the cell.
CONCLUSIONS: XDH and XO may play an important role in a series of pathophysiologic conditions. Their role in hypoxia-reoxygenation injury has been critically reviewed. However, care should be exercised in starting randomized trials to prevent hypoxia-reoxygenation injury with allopurinol, especially in newborn infants. SPECULATION: XDH and XO are released from the liver during hypoxic conditions, for instance, and consequently, they may reach a number of organs via the circulation.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8668378

Source DB:  PubMed          Journal:  Pediatrics        ISSN: 0031-4005            Impact factor:   7.124


  23 in total

1.  Cardioprotective effects of N-hydroxyguanidine PR5 in myocardial ischaemia and reperfusion in rats.

Authors:  M Veveris; M Dambrova; H Cirule; D Meirena; I Kalvinsh; J E Wikberg
Journal:  Br J Pharmacol       Date:  1999-11       Impact factor: 8.739

2.  Effect of serum insulin on the association between hyperuricemia and incident heart failure.

Authors:  Ravi V Desai; Mustafa I Ahmed; Gregg C Fonarow; Gerasimos S Filippatos; Michel White; Inmaculada B Aban; Wilbert S Aronow; Ali Ahmed
Journal:  Am J Cardiol       Date:  2010-10-15       Impact factor: 2.778

Review 3.  NO/redox disequilibrium in the failing heart and cardiovascular system.

Authors:  Joshua M Hare; Jonathan S Stamler
Journal:  J Clin Invest       Date:  2005-03       Impact factor: 14.808

Review 4.  Redox regulation of endothelial canonical transient receptor potential channels.

Authors:  Donna L Cioffi
Journal:  Antioxid Redox Signal       Date:  2011-05-25       Impact factor: 8.401

Review 5.  Therapeutic effects of xanthine oxidase inhibitors: renaissance half a century after the discovery of allopurinol.

Authors:  Pál Pacher; Alex Nivorozhkin; Csaba Szabó
Journal:  Pharmacol Rev       Date:  2006-03       Impact factor: 25.468

6.  Thyroxine prevents reoxygenation injury in isolated proximal tubule cells.

Authors:  Elif Erkan; Abdullah Sakarcan; Gonca Haklar; Suha Yalcin
Journal:  Pediatr Nephrol       Date:  2003-05-07       Impact factor: 3.714

7.  Resuscitation with 100% O(2) does not protect the myocardium in hypoxic newborn piglets.

Authors:  W B Børke; B H Munkeby; L Mørkrid; E Thaulow; O D Saugstad
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2004-03       Impact factor: 5.747

8.  Effect of high-dose allopurinol on exercise in patients with chronic stable angina: a randomised, placebo controlled crossover trial.

Authors:  Awsan Noman; Donald S C Ang; Simon Ogston; Chim C Lang; Allan D Struthers
Journal:  Lancet       Date:  2010-06-09       Impact factor: 79.321

9.  Pharmacological neuroprotection after perinatal hypoxic-ischemic brain injury.

Authors:  Xiyong Fan; Annemieke Kavelaars; Cobi J Heijnen; Floris Groenendaal; Frank van Bel
Journal:  Curr Neuropharmacol       Date:  2010-12       Impact factor: 7.363

10.  Predictive Value of Elevated Uric Acid in Turkish Patients Undergoing Primary Angioplasty for ST Elevation Myocardial Infarction.

Authors:  Ozgur Akgul; Huseyin Uyarel; Hamdi Pusuroglu; Mehmet Gul; Nilgun Isiksacan; Selahattin Turen; Mehmet Erturk; Ozgur Surgit; Mustafa Cetin; Umit Bulut; Omer Faruk Baycan; Nevzat Uslu
Journal:  Acta Cardiol Sin       Date:  2014-03       Impact factor: 2.672

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.